We hypothesized that pulmonary granulocyte-macrophage colony-stimulating fa
ctor (GM-CSF) is critically involved in determining the functional capabili
ties of alveolar macrophages (AM) for host defense. To test this hypothesis
, cells were collected by lung lavage from GM-CSF mutant mice [GM(-/-)] and
C57BL/6 wild-type mice. GM(-/-) mice yielded almost 4-fold more AM than wi
ld-type mice. The percentage of cells positive for the beta (2)-integrins C
D11a and CD11c was reduced significantly in GM(-/-) AM compared with wild-t
ype cells, whereas expression of CD11b was similar in the two groups. The p
hagocytic activity of GM(-/-) AM for FITC-labeled microspheres was impaired
significantly compared with that of wild-type AM both in vitro and in vivo
(after intratracheal inoculation with FITC-labeled beads). Stimulated secr
etion of tumor necrosis factor-alpha (TNF-alpha) and leukotrienes by AM fro
m the GM(-/-) mice was greatly reduced compared with wild-type AM, whereas
secretion of monocyte chemoattractant protein-1 was increased. Transgenic e
xpression of GM-CSF exclusively in the lungs of GM(-/-) mice resulted in AM
with normal or supranormal expression of CD11a and CD11c, phagocytic activ
ity, and TNF-alpha secretion. Thus, in the absence of GMCSF, AM functional
capabilities for host defense were significantly impaired but were restored
by lung-specific expression of GM-CSF.